Physician
Childrens Hospital of the Kings Daughters INC
Childrens Hospital of the Kings Daughters INC was paid $8.38M by Medicaid between Jan 2018 and Dec 2024, across 63 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 24% of everything it billed.
33Billing provider infoCHILDRENS HOSPITAL OF THE KINGS DAUGHTERS INC
NORFOLK, VA 23507
NORFOLK, VA 23507
33aNPI1306992136assigned 01/26/2007
33bProvider typePediatrics Physician
28Total paid$8.38M
24GClaims240,280
24DCodes billed63
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Pediatrics Physician providers in Virginia
Rank by total paid#10 of 817
Median peer was paid$29K
This provider vs. median286×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official ABSHIRE, KATHRYN controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 24,599 | $898K | |
| 2019 | 47,216 | $1.63M | |
| 2020 | 47,809 | $1.52M | |
| 2021 | 44,668 | $1.32M | |
| 2022 | 26,157 | $1.01M | |
| 2023 | 28,565 | $1.14M | |
| 2024incomplete | 21,266 | $860K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 24% | 35,792 | 33,787 | $1.99M |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 17% | 17,094 | 16,264 | $1.40M |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 15% | 16,744 | 16,373 | $1.28M |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 15% | 18,122 | 15,140 | $1.23M |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 11% | 12,020 | 11,644 | $887K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 5.2% | 5,382 | 5,237 | $436K |
| 90686 | 1.9% | 13,417 | 13,053 | $162K | |
| 92551 | 1.3% | 10,305 | 9,953 | $111K | |
| 90670 | 1.3% | 6,297 | 6,069 | $108K | |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | 1.1% | 9,640 | 5,655 | $89K |
| 90698 | 1.0% | 6,140 | 5,920 | $86K | |
| 96161 | <1% | 28,749 | 25,976 | $65K |
51 more codes
| 96127 | <1% | 11,674 | $62K | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 1,964 | $61K |
| 99205 | Prolong outpt/office vis | <1% | 342 | $52K |
| 99381 | <1% | 679 | $51K | |
| 90651 | <1% | 1,600 | $37K | |
| 90680 | <1% | 2,506 | $35K | |
| 99188 | <1% | 1,379 | $32K | |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 266 | $31K |
| 90633 | <1% | 2,350 | $28K | |
| 96160 | <1% | 9,715 | $23K | |
| 90744 | <1% | 1,925 | $22K | |
| 99417 | Prolong home eval add 15m | <1% | 344 | $19K |
| 99199 | Unlisted special service, procedure or report | <1% | 2,102 | $15K |
| 99173 | <1% | 4,398 | $11K | |
| 90734 | <1% | 412 | $8K | |
| 90672 | <1% | 541 | $6K | |
| 99174 | <1% | 898 | $5K | |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 66 | $5K |
| 90710 | <1% | 234 | $4K | |
| 90696 | <1% | 219 | $3K | |
| S9083 | Global fee urgent care centers | <1% | 27 | $2K |
| 90671 | <1% | 74 | $2K | |
| 90707 | <1% | 182 | $2K | |
| 90619 | <1% | 59 | $2K | |
| 90677 | <1% | 37 | $2K | |
| 1128F | <1% | 11,128 | $2K | |
| 90716 | <1% | 102 | $2K | |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 66 | $2K |
| 0072A | <1% | 36 | $2K | |
| 0001A | <1% | 59 | $1K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 89 | $1K |
| 90715 | <1% | 84 | $1K | |
| 99383 | <1% | 12 | $1K | |
| 94618 | <1% | 41 | $969.09 | |
| 90697 | <1% | 31 | $846.70 | |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 13 | $780.57 |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 20 | $600.40 |
| 0002A | <1% | 14 | $592.80 | |
| 91321 | <1% | 18 | $510.00 | |
| 0071A | <1% | 12 | $507.60 | |
| 90620 | <1% | 25 | $459.14 | |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | <1% | 15 | $205.46 |
| 1127F | <1% | 2,447 | $75.00 | |
| 99051 | <1% | 77 | $52.90 | |
| 91300 | <1% | 180 | $0.14 | |
| G9920 | Screening performed and negative | 0% | 1,230 | $0.00 |
| G9919 | Screening performed and positive and provision of recommendations | 0% | 82 | $0.00 |
| J8499 | Prescription drug, oral, non chemotherapeutic, nos | 0% | 40 | $0.00 |
| G8510 | Screening for depression is documented as negative, a follow-up plan is not required | 0% | 616 | $0.00 |
| 91307 | 0% | 135 | $0.00 | |
| J8540 | Dexamethasone, oral, 0.25 mg | 0% | 13 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialABSHIRE, KATHRYN (SENIOR VP CFO)
Parent organizationCHILDRENS HOSPITAL OF THE KINGS DAUGHTERS INC
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.